Holen Sie sich die Stockscreener-App
22.85
3.16%
0.70
Handel nachbörslich:
23.11
0.26
+1.14%
Schlusskurs vom Vortag:
$22.15
Offen:
$22.05
24-Stunden-Volumen:
6.72M
Relative Volume:
0.95
Marktkapitalisierung:
$11.35B
Einnahmen:
$4.45B
Nettoeinkommen (Verlust:
$205.00M
KGV:
57.12
EPS:
0.4
Netto-Cashflow:
$372.00M
1W Leistung:
+2.60%
1M Leistung:
+10.71%
6M Leistung:
+134.36%
1J Leistung:
+81.35%
1-Tages-Spanne:
$21.90
$22.95
1-Wochen-Bereich:
$21.80
$22.95
52-Wochen-Spanne:
$8.02
$22.95
Elanco Animal Health Inc Stock (ELAN) Company Profile
Firmenname
Elanco Animal Health Inc
Sektor
Telefon
877-352-6261
Adresse
2500 INNOVATION WAY, GREENFIELD
Vergleichen Sie ELAN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
22.85 | 11.00B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
144.35 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.42 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.38 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.52 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
438.66 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-07-17 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Eingeleitet | UBS | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-09-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-19 | Eingeleitet | Jefferies | Buy |
| 2023-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-04-20 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Sell |
| 2022-07-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-06-15 | Hochstufung | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Eingeleitet | Stifel | Buy |
| 2021-03-22 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Herabstufung | Argus | Buy → Hold |
| 2020-11-09 | Herabstufung | Barclays | Overweight → Underweight |
| 2020-08-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-08-04 | Fortgesetzt | Goldman | Buy |
| 2020-07-27 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-19 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Eingeleitet | Barclays | Overweight |
| 2019-08-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-03-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Eingeleitet | William Blair | Mkt Perform |
| 2019-01-23 | Eingeleitet | UBS | Sell |
| 2019-01-15 | Eingeleitet | Argus | Buy |
| 2018-10-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten
Veterinary Medicine Market Size, Share, Trends & Forecast 2032 - SkyQuest Technology
Elanco (ELAN) To Report Earnings Tomorrow: Here Is What To Expect - FinancialContent
Best data tools to analyze Elanco Animal Health Incorporated stockTrade Analysis Report & AI Powered Buy/Sell Recommendations - newser.com
How cyclical is Elanco Animal Health Incorporated (5EA) stock compared to rivals2025 Volatility Report & Safe Entry Momentum Tips - newser.com
What insider purchases suggest about Elanco Animal Health Incorporated (5EA) stockEarnings Overview Summary & Accurate Buy Signal Notifications - newser.com
Why institutional investors increase stakes in Elanco Animal Health Incorporated stockProfit Target & Fast Gain Swing Trade Alerts - newser.com
Livestock Healthcare Market Projections 2025-2032: Key - openPR.com
What to expect from Elanco Animal Health Incorporated in the next 30 daysPortfolio Return Summary & Capital Protection Trade Alerts - newser.com
Is Elanco Animal Health Incorporated stock bottoming outFed Meeting & Low Drawdown Trading Techniques - newser.com
Is Elanco Animal Health Incorporated meeting your algorithmic filter criteriaJuly 2025 Update & AI Optimized Trading Strategy Guides - newser.com
How to integrate Elanco Animal Health Incorporated into portfolio analysis toolsPortfolio Update Summary & Pattern Based Trade Signal System - newser.com
How Expanded Parasiticide Approvals and Emergency Use Authorization at Elanco (ELAN) Have Changed Its Investment Story - simplywall.st
Risk vs reward if holding onto Elanco Animal Health IncorporatedJuly 2025 Rallies & Safe Capital Allocation Plans - newser.com
Will Elanco Animal Health Incorporated (5EA) stock boost dividends further2025 Institutional Moves & Fast Exit and Entry Strategy Plans - newser.com
Published on: 2025-11-02 21:36:11 - newser.com
Will Elanco Animal Health Incorporated (5EA) stock benefit from infrastructure bill2025 Top Gainers & Stepwise Trade Signal Implementation - newser.com
Will Elanco Animal Health Incorporated stock recover faster than marketQuarterly Profit Report & Fast Entry and Exit Trade Plans - newser.com
Is Elanco Animal Health Incorporated stock cheap at current valuationEarnings Growth Summary & Consistent Return Strategy Ideas - newser.com
Elanco Animal Health Incorporated stock prediction for this weekJuly 2025 Selloffs & Expert-Curated Trade Recommendations - newser.com
Elanco Animal Health (NYSE:ELAN) Downgraded to Buy Rating by Wall Street Zen - MarketBeat
Elanco Animal Health Incorporated’s volatility index tracking explainedMarket Trend Report & AI Driven Price Forecasts - newser.com
Jennison Associates LLC Has $46.19 Million Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Hits New 52-Week High of $22.86 - Markets Mojo
Companion Animal Health Market to Worth USD 61.74 Billion by 2034, Driven by Rising Pet Ownership and Humanization Trends - GlobeNewswire Inc.
Is Elanco Animal Health Incorporated (5EA) stock attractive for growth fundsWeekly Investment Recap & Expert Curated Trade Ideas - newser.com
What high frequency data says about Elanco Animal Health IncorporatedMarket Growth Review & Free Technical Pattern Based Buy Signals - newser.com
Is Elanco Animal Health Incorporated (5EA) stock a buy on weaknessQuarterly Portfolio Review & Daily Momentum Trading Reports - newser.com
News impact scoring models applied to Elanco Animal Health IncorporatedSell Signal & Real-Time Buy Zone Alerts - newser.com
Why Elanco Animal Health Incorporated (5EA) stock stays resilientJuly 2025 Momentum & Technical Pattern Based Signals - newser.com
Rising Trends of Thermostable Poultry Vaccine Market Growth - openPR.com
Peering Into Elanco Animal Health Inc's Recent Short Interest - Sahm
Is Elanco Animal Health Incorporated stock poised for growthExit Point & Daily Stock Trend Reports - newser.com
Will Elanco Animal Health Incorporated stock benefit from Fed rate cutsWeekly Market Report & AI Forecasted Entry/Exit Points - newser.com
Published on: 2025-10-30 23:29:20 - newser.com
Elanco Animal Health Hits New 52-Week High of $22.73 - Markets Mojo
Elanco's Credelio™ (Lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) Against New World Screwworm (NWS) in Dogs - ReportAlert
Elanco Animal Health (ELAN) to Release Quarterly Earnings on Wednesday - MarketBeat
Published on: 2025-10-30 06:31:33 - newser.com
Finanzdaten der Elanco Animal Health Inc-Aktie (ELAN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
2.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):